Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial By: CNBC.com News November 19, 2024 at 16:04 PM EST Eli Lilly’s cholesterol pill impressed in a mid-stage trial. Meanwhile, Dexcom invested $75 million in Oura. Read More >>
